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Background
The Canadian Institutes of Health Research (CIHR)
defines knowledge translation (KT) as a dynamic and
iterative process that includes the synthesis, dissemination,
exchange, and ethically-sound application of knowledge to
improve the health of Canadians, provide more effective
health services and products, and strengthen the health-
care system. CIHR, the national health research funding
agency in Canada, undertook to advance this concept
through direct research funding opportunities in KT. Out
of a desire to base future programming decisions on evi-
dence, CIHR undertook to critically evaluate the results of
this KT funding program.
Materials and methods
The evaluation employed a method of participatory, utili-
zation-focused evaluation inspired by the principles of
integrated KT. It used a mixed methods approach, draw-
ing on both quantitative and qualitative data, and sought
participation from funded researchers, knowledge users, as
well as other health research funding agencies from
around the world. Lines of inquiry included an interna-
tional organizational scan (n=26), document/data reviews,
in-depth qualitative interviews (n=37), targeted on-line
surveys (n=379), and case studies (n=5).
Results
The evaluation uncovered that the KT funding opportu-
nities performed well against typical measures of research
success (ie. academic outputs, training objectives, KT out-
puts), but also, that they performed well against less typical
measures such as positioning research for use and actual
knowledge application. Data indicate that KT funding
opportunities contribute to the fulfillment of the CIHR
mandate in a way that is complementary to “investigator-
driven” open research. For example, KT funded researchers
report that they contribute more often to improving health,
strengthening the health care system, and the creation of
health services and/or products, whereas open funded
researchers report contributing more often to the creation
of new health knowledge.
Conclusions
CIHR’s KT Funding Program has performed well in terms
of meeting expected and producing positive unexpected
outcomes. Moreover, it has helped to position CIHR for
success in an area that is of increasing significance to
health research funders across the world. Given that the
concept of evidence-based practice and policy is growing
in significance, the dissemination of this study (methods
and results) will help to fill a gap in knowledge in three
areas: the role of a public research funding agency in facili-
tating KT, the outcomes and impacts KT funding interven-
tions, and how KT can best be evaluated.
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